Table 5.

Clinical Outcomes

	Normal Weight	Overweight	Obese	p-value
Median Follow-up (months)	22 (2–144)	29 (2–187)	25 (1–183)
Recurrence Rate	57.4%	48.8%	53.4%	0.679
Median Time to Recurrence (yrs)	2.62	5.20	2.46	0.749
Site of Recurrence				0.269
Pelvis	13 (41.9%)	8 (38.1%)	7 (21.9%)
Distant	17 (54.8%)	13 (61.9%)	23 (71.9%)
Treatment at Recurrence				0.990
None	9 (29.0%)	4 (19.0%)	7 (21.9%)
Radiation alone	2 (6.5%)	1 (4.8%)	3 (9.4%)
Chemotherapy alone	9 (29.0%)	5 (23.8%)	6 (18.8%)
Surgery	2 (6.5%)	2 (9.5%)	4 (12.5%)
Chemoradiation	4 (12.9%)	4 (19.0%)	4 (12.5%)
Surgery + Chemotherapy	1 (3.2%)	2 (9.5%)	3 (9.4%)
Surgery + Radiation	1 (3.2%)	1 (4.8%)	1 (3.1%)
Surgery + Chemoradiation	1 (3.2%)	2 (9.5%)	1 (3.1%)
Chemotherapy + Hormone Therapy	1 (3.2%)	0 (0%)	0 (0%)
Unknown	1 (3.2%)	0 (0%)	3 (9.4%)
Current Status				0.085
NED	13 (22%)	19 (43.2%)	19 (32.8%)
Alive with disease	0 (0%)	0 (0%)	6 (10.3%)
Died of disease	30 (50.8%0	17 (38.6%)	20 (34.5%)
Died of complication	5 (8.5%)	3 (6.8%)	4 (6.9%)
Died of other causes	11 (18.7%)	5 (11.4%)	9 (15.5%)